Profile: Devax, Inc. is a medical device company which develops products for interventional cardiology. Our product is AXXESS™ bifurcation stent system. Our AXXESS™ Biolimus A9® eluting bifurcation stent system is a proprietary self-expanding nitinol stent specifically engineered for the treatment of coronary and vascular bifurcation lesions. The stent is coated with biolimus A9®, a drug uniquely formulated to prevent restenosis in a coronary artery and a next-generation bioabsorbable polymer, polylactic acid (PLA), which is designed to release the drug over time. The conical shape of the stent is specifically designed to conform to the anatomy of the bifurcation and to provide interventional cardiologists with the ability to treat the bifurcation without compromising access to the side branch.

The company has ~30 employees.